Lv41
472 积分 2025-05-28 加入
Variant allele frequency: a decision-making tool in precision oncology?
4天前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
28天前
已完结
[Chinese expert consensus on clinical testing standards of PD-L1 expression for non-small cell lung cancer (2023 version)]
1个月前
已完结
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
1个月前
已完结
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer
2个月前
已完结
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer
2个月前
已完结
[Expert consensus on folate receptor α immunohistochemical testing in ovarian cancer and its clinical applications (2025 version)]
2个月前
已完结
Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
2个月前
已完结
The target atlas for antibody-drug conjugates across solid cancers
2个月前
已完结
皖公网安备34019202002308
